← All trials
NCT02668315
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2016
- Primary completion
- Jun 1, 2018
- Completion date
- Jan 1, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 25
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- University of MontrealLead sponsor
- Canadian Institutes of Health Research (CIHR)Collaborator
- Canadian Cancer SocietyCollaborator
- University of MontrealReponsible party - principal investigator
- Hopital de l'Enfant-JesusCollaborator
- University of MontrealCollaborator
- University of British ColumbiaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.